SCHEMBL12366146

SCHEMBL12366146

[C-]#[N+]CC(=O)NCc1ccc(OC(F)(F)F)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 4/20 0.53
NR1H4 Q96RI1 1/20 0.53
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA7 P43166 1/20 0.52
HTR2C P28335 3/20 0.49
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
PPARA Q07869 3/20 0.46
PPARG P37231 2/20 0.46
NLRP3 Q96P20 1/20 0.45
PLA2G1B P04054 1/20 0.45
MAPT P10636 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ATG4B Q9Y4P1 1/20 0.45
LTA4H P09960 1/20 0.44
OPRM1 P35372 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23564738 0.81 EPHX2 (0.57) EPHX2NR1H4CA12CA1CA2
SCHEMBL31248368 0.81 EPHX2 (0.57) EPHX2NR1H4CA12CA1CA2
SCHEMBL12366117 0.81 HDAC1 (0.56) EPHX2CA12CA1CA2CA7
SCHEMBL934006 0.81 EPHX2 (0.60) EPHX2NR1H4CA12CA1CA2
SCHEMBL19212325 0.81 EPHX2 (0.57) EPHX2NR1H4CA12CA1CA2
SCHEMBL12366188 0.79 LMNA (0.47) CA12CA1CA2CA7SMN1; SMN2
SCHEMBL12366135 0.79 LMNA (0.62) CA12CA1CA2PLA2G1BSMN1; SMN2
SCHEMBL6635990 0.79 EPHX2 (0.61) EPHX2NR1H4CA12CA1CA2
SCHEMBL933617 0.78 EPHX2 (0.58) EPHX2NR1H4CA12CA1CA2
SCHEMBL12366144 0.78 HPGD (0.54) EPHX2CYP3A4PPARAPPARGSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed